These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 27872073)
1. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen. Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073 [TBL] [Abstract][Full Text] [Related]
2. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560 [TBL] [Abstract][Full Text] [Related]
3. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848 [TBL] [Abstract][Full Text] [Related]
4. Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans. Becka SA; Zeiser ET; Marshall SH; Gatta JA; Nguyen K; Singh I; Greco C; Sutton GG; Fouts DE; LiPuma JJ; Papp-Wallace KM Diagn Microbiol Infect Dis; 2018 Nov; 92(3):253-258. PubMed ID: 29983287 [TBL] [Abstract][Full Text] [Related]
6. Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam. Alsenani TA; Viviani SL; Kumar V; Taracila MA; Bethel CR; Barnes MD; Papp-Wallace KM; Shields RK; Nguyen MH; Clancy CJ; Bonomo RA; van den Akker F Antimicrob Agents Chemother; 2022 Apr; 66(4):e0241421. PubMed ID: 35341315 [TBL] [Abstract][Full Text] [Related]
7. Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Nukaga M; Yoon MJ; Taracilia MA; Hoshino T; Becka SA; Zeiser ET; Johnson JR; Papp-Wallace KM ACS Infect Dis; 2021 Apr; 7(4):826-837. PubMed ID: 33723985 [No Abstract] [Full Text] [Related]
8. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa. Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA mBio; 2018 Dec; 9(6):. PubMed ID: 30538183 [No Abstract] [Full Text] [Related]
10. Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase. Papp-Wallace KM; Becka SA; Taracila MA; Winkler ML; Gatta JA; Rholl DA; Schweizer HP; Bonomo RA Antimicrob Agents Chemother; 2016 Feb; 60(2):777-88. PubMed ID: 26596949 [TBL] [Abstract][Full Text] [Related]
11. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop. Winkler ML; Papp-Wallace KM; Bonomo RA J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381 [TBL] [Abstract][Full Text] [Related]
12. Activity of Imipenem-Relebactam against Multidrug- and Extensively Drug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli. Becka SA; Zeiser ET; LiPuma JJ; Papp-Wallace KM Antimicrob Agents Chemother; 2021 Oct; 65(11):e0133221. PubMed ID: 34370574 [TBL] [Abstract][Full Text] [Related]
13. Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a cystic fibrosis patient. Stokell JR; Gharaibeh RZ; Steck TR J Cyst Fibros; 2013 Dec; 12(6):812-6. PubMed ID: 23478130 [TBL] [Abstract][Full Text] [Related]
14. Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases. Degrossi JJ; Merino C; Isasmendi AM; Ibarra LM; Collins C; Bo NE; Papalia M; Fernandez JS; Hernandez CM; Papp-Wallace KM; Bonomo RA; Vazquez MS; Power P; Ramirez MS Curr Microbiol; 2019 Apr; 76(4):485-494. PubMed ID: 30783798 [TBL] [Abstract][Full Text] [Related]
15. Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. Papp-Wallace KM; Taracila MA; Gatta JA; Ohuchi N; Bonomo RA; Nukaga M J Biol Chem; 2013 Jun; 288(26):19090-102. PubMed ID: 23658015 [TBL] [Abstract][Full Text] [Related]
16. Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del. Yi H; Kim K; Cho KH; Jung O; Kim HS Antimicrob Agents Chemother; 2012 Jul; 56(7):4005-8. PubMed ID: 22564834 [TBL] [Abstract][Full Text] [Related]
17. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam. Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153 [TBL] [Abstract][Full Text] [Related]
18. Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution. Yi H; Cho KH; Cho YS; Kim K; Nierman WC; Kim HS PLoS One; 2012; 7(5):e37585. PubMed ID: 22629423 [TBL] [Abstract][Full Text] [Related]
19. Van Dalem A; Herpol M; Echahidi F; Peeters C; Wybo I; De Wachter E; Vandamme P; Piérard D Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914964 [TBL] [Abstract][Full Text] [Related]
20. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase. Petrosino JF; Palzkill T J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]